Regeneron Pharmaceuticals (REGN) Non-Current Deffered Revenue (2009 - 2026)
Regeneron Pharmaceuticals (REGN) posted Non-Current Deffered Revenue of $220.4 million for Q2 2026, up 6.8% from $206.3 million a year earlier but down 2.1% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Non-Current Deffered Revenue (2009 - 2026) Analysis & Trends
At the end of FY2025, Regeneron Pharmaceuticals' Non-Current Deffered Revenue came in at $208.7 million, up 12.4% from FY2024.
- Annual Non-Current Deffered Revenue has increased for three consecutive years, with a five-year compound annual growth rate of 29.3% (FY2020 to FY2025).
- In prior years, Regeneron Pharmaceuticals' Non-Current Deffered Revenue was $185.7 million in FY2024 (+46.6%), $126.7 million in FY2023 (+81.5%), $69.8 million in FY2022 (-4.8%) and $73.3 million in FY2021 (+26.8%).
- Quarterly Non-Current Deffered Revenue has run from a low of $33.5 million in Q1 2022 to a high of $225.1 million in Q1 2026 over five years.
- On a year-over-year basis, Non-Current Deffered Revenue has increased in each of the last 14 quarters, with growth averaging 19.7% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q1 2023, with growth of 155.2%; the weakest was Q3 2021, with a decline of 46.1%.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $225.1 million (Q1 2026), $208.7 million (Q4 2025) and $219.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | - |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | - |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | - |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | - |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | - |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 220.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 220.40 Mn |
| Mar 31, 2026 | 225.10 Mn |
| Dec 31, 2025 | 208.70 Mn |
| Sep 30, 2025 | 219.20 Mn |
| Jun 30, 2025 | 206.30 Mn |
| Mar 31, 2025 | 211.80 Mn |
| Dec 31, 2024 | 185.70 Mn |
| Sep 30, 2024 | 207.40 Mn |
| Jun 30, 2024 | 205.60 Mn |
| Mar 31, 2024 | 185.80 Mn |
| Dec 31, 2023 | 126.70 Mn |
| Sep 30, 2023 | 125.30 Mn |
| Jun 30, 2023 | 116.20 Mn |
| Mar 31, 2023 | 85.50 Mn |
| Dec 31, 2022 | 69.80 Mn |
| Sep 30, 2022 | 60.10 Mn |
| Jun 30, 2022 | 58.70 Mn |
| Mar 31, 2022 | 33.50 Mn |
| Dec 31, 2021 | 73.30 Mn |
| Sep 30, 2021 | 56.50 Mn |
API Access
Regeneron Pharmaceuticals Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();